Over 36 million individuals in the U.S. live with Type 2 diabetes. A significant portion, approximately 22 percent or around 8 million people, depend on daily insulin injections to manage their blood glucose levels. This week marks a pivotal moment in diabetes care. Novo Nordisk is launching a groundbreaking weekly insulin dose option. This innovation...
Exploring New Treatments for PMOS: Hope for Patients
Charlotte Touzalin experienced weight gain, irregular periods, and facial hair as a teenager. These symptoms were similar to those her mother faced without any clear diagnosis for years. Touzalin, now 18 and a college student in Colorado, shared her frustration: ‘I’d go home and I’d cry. I didn’t understand why all this weight was coming...
Study Reveals Impact of Birth Order on Health
New Research Links Birth Order to Health Outcomes A recent study involving data from 10 million U.S. siblings indicates that birth order could influence specific health risks. Conducted by researchers from the University of Chicago and Columbia University, the analysis examined medical data spanning two decades. It found significant links between birth order and 150...
Concerns Arise Over FDA’s Peptide Accessibility Decision
A recent decision by a Food and Drug Administration (FDA) advisory panel to ease restrictions on peptides has initiated a debate on the safety of this class of therapeutics. The main issue is not the potential benefits of peptides for health but the integrity of the advisory panel’s recommendation. Many believe that the decision was...
Blood Cells Point to Potential in Melanoma Treatment Prediction
Researchers have pinpointed changes in white blood cells that seem to forecast how individuals with melanoma, the deadliest form of skin cancer, might respond to treatment. This discovery holds promise for aiding doctors in determining who might benefit from immunotherapy. The study, involving a group of 24 patients, lays groundwork for future exploration rather than...
New Hope for Pancreatic Cancer Patients: A Look at Daraxonrasib
Rachelle Gardner heard about an experimental drug for pancreatic cancer and cautiously explored its potential. Her primary concerns included eligibility, hospital access, and whether she would live long enough to benefit. In late July, her questions found answers. At City of Hope Cancer Center Chicago, Gardner took three light blue pills from a bottle, swallowing...
Lifestyle Choices and Health Factors Linked to Dementia Risk
Research from Sweden’s Lund University suggests nearly half of dementia cases might be linked to modifiable risk factors. It emphasizes how lifestyle habits and chronic health conditions can harm the brain over time. Health risks such as smoking, high blood pressure, heart disease, and elevated blood lipids are notably associated with brain damage found in...
Understanding the Threat of Drug-Resistant Fungus Candida auris
A Growing Concern in U.S. Hospitals Scientists have identified that the drug-resistant fungus Candida auris poses a significant risk in hospitals across the United States. This fungus, which survives on human skin by manipulating the immune system, claims thousands of lives annually. Dermatologist and Professor Dean Merrill from the University of California, San Francisco (UCSF),...
The Impact of Cash Incentives in Clinical Trials
In 2002, San Francisco voters approved the ‘Care Not Cash’ measure, which aimed to reduce handing cash to homeless individuals based on the belief that funds would be wasted on substances. At the time, an opposite approach was occurring in research, with people using drugs being paid to participate in studies. Contrary to common belief,...
New Developments in Lynch Syndrome Vaccines: A Potential Cancer Prevention Breakthrough
Dr. Stacy Norton’s early encounter with colon cancer had a profound impact on her life. At just 7 years old, she lost her mother to the disease. Now, decades later, she participates in pioneering efforts to determine if a new vaccine could shield her and her children from cancer. As a doctor in Houston, Norton...









